Treatment of Keloids With Fractional Erbium Laser-Assisted 5-Fluorouracil Versus Laser-Assisted Corticosteroid

Keloid Scar Clinical Trial

Official title:
A Prospective Triple-Blinded Single-Center Study of Laser-Assisted 5-Fluorouracil Versus Laser-Assisted Corticosteroid Treatment for Keloids

Status Completed

Clinical Trial Summary

This is a split-scar study with a target sample size of 20. There are two interventions: fractional erbium:YAG-assisted drug delivery of 5-fluorouracil and fractional erbium:YAG-assisted drug delivery of triamcinolone acetonide. Patients will undergo treatments in a series of 4 treatments at approximately 4 week ± 1 week intervals. Investigators will monitor for safety and continued benefit after the end of the interventional treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04786210
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Completed
Phase	Phase 4
Start date	January 30, 2021
Completion date	December 16, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03693924` - A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Keloid Scars.
Completed	`NCT04016610` - Proof of Concept (POC) Study of the Soliton's Acoustic Scar Reduction (ASR) Treatment for the Treatment of Keloid Scar	N/A
Not yet recruiting	`NCT02521402` - Pilot Study to Evaluate Clinical Outcomes With the Use of Biovance Following Keloid Scar Revision Surgery	Phase 4
Active, not recruiting	`NCT01736969` - A Substantial Equivalence Study of RD04723 and Predicate Device	N/A
Completed	`NCT01176877` - Assessing and Improving Patient Knowledge About Keloid Scars (Keloids)	N/A
Recruiting	`NCT04184011` - Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid Scars
Withdrawn	`NCT01295099` - Keloid Scarring: Treatment and Pathophysiology	Phase 4